These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 23389838

  • 1. Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.
    Caron V, Hu Y, Tajber L, Erxleben A, Corrigan OI, McArdle P, Healy AM.
    AAPS PharmSciTech; 2013 Mar; 14(1):464-74. PubMed ID: 23389838
    [Abstract] [Full Text] [Related]

  • 2. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 3. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY, Lin HL, Chi YT, Huang YT, Kao CY, Hsieh WH.
    Int J Pharm; 2015 Dec 30; 496(2):457-65. PubMed ID: 26481469
    [Abstract] [Full Text] [Related]

  • 4. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X, Xu T, Huang W, Fan B, Sheng X.
    AAPS PharmSciTech; 2019 Mar 18; 20(4):143. PubMed ID: 30887265
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S.
    Int J Pharm; 2019 Jan 10; 554():190-200. PubMed ID: 30414899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H, Lawrence MJ, Shah S, Moghul H, Al-Saden N, Bari F.
    Int J Pharm; 2013 Mar 25; 446(1-2):100-5. PubMed ID: 23410988
    [Abstract] [Full Text] [Related]

  • 13. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
    Piccinni P, Tian Y, McNaughton A, Fraser J, Brown S, Jones DS, Li S, Andrews GP.
    J Pharm Pharmacol; 2016 May 25; 68(5):705-20. PubMed ID: 26864155
    [Abstract] [Full Text] [Related]

  • 14. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA, Neau SH.
    Drug Dev Ind Pharm; 2016 Mar 25; 42(3):446-455. PubMed ID: 26266965
    [Abstract] [Full Text] [Related]

  • 15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 25; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R, Sieger P, Karmwar P.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):723-31. PubMed ID: 23684913
    [Abstract] [Full Text] [Related]

  • 18. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
    Kini A, Patel SB.
    Pharm Dev Technol; 2017 Feb 16; 22(1):45-57. PubMed ID: 26853838
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A, Strachan CJ, Veski P, Aaltonen J, Heinämäki J, Yliruusi J, Kogermann K.
    Int J Pharm; 2015 Feb 16; 486(1-2):306-14. PubMed ID: 25843761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.